568 related articles for article (PubMed ID: 33149582)
1. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
[TBL] [Abstract][Full Text] [Related]
2. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
3. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
[No Abstract] [Full Text] [Related]
4. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
[TBL] [Abstract][Full Text] [Related]
5. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
6. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
Li J; Du X; Zheng N; Xu L; Xu J; Li S
Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
[TBL] [Abstract][Full Text] [Related]
7. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
[TBL] [Abstract][Full Text] [Related]
8. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
9. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
[TBL] [Abstract][Full Text] [Related]
10. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
He Y; Luo L; Liang S; Long M; Xu H
J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
12. Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT pH-triggered delivery.
Llinàs MC; Martínez-Edo G; Cascante A; Porcar I; Borrós S; Sánchez-García D
Drug Deliv; 2018 Nov; 25(1):1137-1146. PubMed ID: 29779394
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
14. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
15. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer.
Xu P; Yao J; Li Z; Wang M; Zhou L; Zhong G; Zheng Y; Li N; Zhai Z; Yang S; Wu Y; Zhang D; Dai Z
Int J Nanomedicine; 2020; 15():2659-2668. PubMed ID: 32368047
[TBL] [Abstract][Full Text] [Related]
17. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
[TBL] [Abstract][Full Text] [Related]
19. DPP-Cu
Chen W; Ma M; Lai Q; Zhang Y; Liu Z
Curr Med Chem; 2023; 30(28):3249-3260. PubMed ID: 36221869
[TBL] [Abstract][Full Text] [Related]
20. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]